{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:12:25Z","timestamp":1790820745940,"version":"4.1.0"},"reference-count":22,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["accp1.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Pharm in Drug Dev"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study evaluated the safety, pharmacokinetic parameters, and bioequivalence (BE) of pomalidomide (POM) capsules (specification: 4\u00a0mg) acquired from 2 sponsors (test [T] and reference [R]), under fasting and fed conditions. A single\u2010center, randomized, open\u2010label, 2\u2010cycle, self\u2010crossover, single\u2010dose clinical trial was conducted. Subjects were divided into fasting (<jats:italic>n<\/jats:italic>\u00a0=\u00a028) and fed (<jats:italic>n<\/jats:italic>\u00a0=\u00a028) groups and assigned randomized treatment sequences (T\u2010R or R\u2010T). Blood samples for pharmacokinetic evaluation were collected within 48\u00a0hours of administration, and safety was assessed throughout. Exposure to POM was similar following single\u2010oral\u2010dose administrations of T or R between the fasting and fed states. T and R exhibited BE, as demonstrated by statistical analysis; the 90%CIs of the geometric mean ratios of maximum plasma concentration, area under the plasma concentration\u2013time curve (AUC)from time 0 to the last measurable concentration, and AUC from time 0 to infinity were within the acceptable BE range (80%\u2013125%). Administering POM capsules with high\u2010fat meals resulted in a 2.5\u2010hour delay in time to maximum concentration and an \u224820.4% reduction in maximum plasma concentration. However, AUCs were comparable after dose administrations with and without food. The fast and fed groups revealed that POM capsules were tolerated in healthy Chinese male subjects, and so were orally bioavailable in healthy subjects under fasting and fed states.<\/jats:p>","DOI":"10.1002\/cpdd.1173","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T16:04:35Z","timestamp":1664553875000},"page":"1246-1252","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Bioequivalence of Pomalidomide Capsules in Fasting and Fed States in Healthy Male Volunteers: A Randomized, Open, Single\u2010Dose, Biperiodic, Double\u2010Crossover Study"],"prefix":"10.1002","volume":"11","author":[{"given":"Yannan","family":"Wang","sequence":"first","affiliation":[{"name":"Phase I Clinical Research Center Zhejiang Provincial People's Hospital People's Hospital of Hangzhou Medical College  Hangzhou China"},{"name":"People's Hospital of Hangzhou Medical College  Hangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisi","family":"Lin","sequence":"additional","affiliation":[{"name":"Phase I Clinical Research Center Zhejiang Provincial People's Hospital People's Hospital of Hangzhou Medical College  Hangzhou China"},{"name":"People's Hospital of Hangzhou Medical College  Hangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[{"name":"Phase I Clinical Research Center Zhejiang Provincial People's Hospital People's Hospital of Hangzhou Medical College  Hangzhou China"},{"name":"People's Hospital of Hangzhou Medical College  Hangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoyan","family":"Wang","sequence":"additional","affiliation":[{"name":"Phase I Clinical Research Center Zhejiang Provincial People's Hospital People's Hospital of Hangzhou Medical College  Hangzhou China"},{"name":"People's Hospital of Hangzhou Medical College  Hangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,9,30]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-91439-8_8"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-013-0047-x"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0813-1"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16881"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-18-1781"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13905"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-008-0620-4"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2016-0184"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32556-5"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70380-2"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2013.827169"},{"key":"e_1_2_9_13_1","first-page":"89","article-title":"A Phase I, open\u2010label, randomized, crossover study in healthy subjects to evaluate the bioavailability of, and the food effect on, a pomalidomide oral liquid suspension","volume":"10","author":"Li Y","year":"2018","journal-title":"Clin Pharmacol"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-012-2040-6"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1145"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.384"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.470"},{"key":"e_1_2_9_18_1","first-page":"133","article-title":"Population pharmacokinetics of pomalidomide in patients with relapsed or refractory multiple myeloma with various degrees of impaired renal function","volume":"9","author":"Li Y","year":"2017","journal-title":"Clin Pharmacol"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.455"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-015-2912-7"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.114.215251"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.119"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2007.08.043"}],"container-title":["Clinical Pharmacology in Drug Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpdd.1173","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cpdd.1173","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpdd.1173","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T09:50:47Z","timestamp":1692611447000},"score":1,"resource":{"primary":{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/10.1002\/cpdd.1173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,30]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["10.1002\/cpdd.1173"],"URL":"https:\/\/doi.org\/10.1002\/cpdd.1173","archive":["Portico"],"relation":{},"ISSN":["2160-763X","2160-7648"],"issn-type":[{"value":"2160-763X","type":"print"},{"value":"2160-7648","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,30]]},"assertion":[{"value":"2021-10-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-29","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}